INTS
Intensity Therapeutics
$3.34
−$0.04 (−1.18%)Oct 29, 2026
Key metrics
The numbers that frame INTS today
- Market cap
- $10.90M
- ROIC
- -35,721.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.00
- 52wk High
- $43.50
Growth
Revenue and earnings trend for INTS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INTS
Is Intensity Therapeutics a good buy?
No. Intensity Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Intensity Therapeutics is selling at a very high price.
What is the market capitalization of INTS?
Intensity Therapeutics's market capitalization is $10.90M.
What is the 52-week high for INTS stock?
The 52-week high for Intensity Therapeutics is $43.50. The current close of $3.34 is 92.3% below that high.
What is the 52-week low for INTS stock?
The 52-week low for Intensity Therapeutics is $3.00. The current close of $3.34 is 11.3% above that low.
Does INTS stock pay dividends?
Intensity Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for INTS?
Intensity Therapeutics's Debt / Equity ratio is 0.01.